Simone Hashimoto
Overview
Explore the profile of Simone Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin-Gonzalez E, Perez-Garcia J, Herrera-Luis E, Martin-Almeida M, Kebede-Merid S, Hernandez-Pacheco N, et al.
Allergy
. 2025 Feb;
PMID: 39907155
Background: Asthma exacerbations (AEs) represent the major contributor to the global asthma burden. Although genetic and environmental factors have been associated with AEs, the role of epigenetics remains uncovered. Objective:...
2.
Alizadeh Bahmani A, I Abdel-Aziz M, Hashimoto S, Bang C, Brandstetter S, Corcuera-Elosegui P, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857673
: Metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) are common inhaled corticosteroid (ICS) inhaler devices. The difference in formulation and administration technique of these devices may influence oral cavity...
3.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
4.
Alizadeh Bahmani A, Vijverberg S, Hashimoto S, Wolff C, Almqvist C, Bloemsma L, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39687398
Background: Underlying immunological mechanisms in children with moderate-to-severe asthma are complex and unclear. We aimed to investigate the association between blood inflammatory parameters and asthma burden in children with moderate-to-severe...
5.
Khaleva E, Brightling C, Eiwegger T, Altraja A, Begin P, Blumchen K, et al.
Eur Respir J
. 2024 Nov;
PMID: 39510551
Background: We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biologics for severe asthma. We...
6.
van Dijk Y, Keuker V, Hashimoto S, Rutjes N, van Muilekom M, Golebski K, et al.
Pediatr Allergy Immunol
. 2024 Oct;
35(10):e14262.
PMID: 39450694
Background: Fatigue is a commonly reported clinical symptom, yet research on fatigue in children with severe asthma is missing. We aimed to explore the extent of fatigue in severe pediatric...
7.
Lap C, Brackel C, Winkel A, Hashimoto S, Haverkort M, Noij L, et al.
Pediatr Res
. 2024 Sep;
PMID: 39333387
Background: To determine the prevalence of pediatric Post-COVID-19 condition (PPCC), identify risk factors, and assess the quality of life in children with differing severities of acute COVID-19. Methods: During a...
8.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Jul;
PMID: 38954138
No abstract available.
9.
van Dijk Y, Brandsen M, Hashimoto S, Rutjes N, Golebski K, Vermeulen F, et al.
Pediatr Pulmonol
. 2024 Jun;
59(11):2875-2884.
PMID: 38934778
Background & Objectives: Despite the availability of biologics for severe pediatric asthma, real-life studies reporting on drivers behind initiating biologics and their alignment with the Global Initiative for Asthma (GINA)...
10.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Apr;
20(7):682-691.
PMID: 38664324
Background: Pediatric post coronavirus disease 2019 (COVID-19) condition (PPCC) is a heterogeneous syndrome, which can significantly affect the daily lives of children. This study aimed to identify clinically meaningful phenotypes...